Ophthalmology and Ionizing Radiation
Volume 1 - Issue 1
Shravana Kumar Chinnikatti*
-
Author Information
Open or Close
- Consultant Oncologist, Salmaniya Medical Complex, Kingdom of Bahrain
*Corresponding author:
Shravana Kumar Chinnikatti, Consultant Oncologist, Salmaniya Medical Complex, Kingdom of Bahrain
Received: January 18, 2018; Published: January 29, 2018
DOI: 10.32474/TOOAJ.2018.01.000101
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Due to the sensitive nature and low radiation tolerance of eye
and its contents radiation to eye is sparingly and selectively used.
Delivering ionizing radiation to eye associated with complications,
however the intraocular tumors are highly radiosensitive and
radiation can be delivered both by external beam therapy and
brachytheray. Due to recent advances in radiotherapy now particle
beam therapy is preferred for best vision sparing therapy due
its selective nature. External and brachytherapy can radiation
used with intent of radiacal, adjuvant and palliative intent to
most common intraocular tumors like retinoblastoma, choroidal
melanoma and metastatic tumors. Brachytherapy rarely is used
only in selective centers with high technical expertise due high
professional exposure to ionizing radiation. Radiation plaques are
used in brachytherapy and these are the preloaded sources kept
near the tumors either temporarily or permanently. Brachytherapy
most commonly used for choroid melanomas [1]. Brachytherapy
plaques come in different sizes and shapes or can be customized
according to the needs. Brachytherapy basically delivers high
radiation to tumor and less radiation to surrounding normal tissues.
Editorial|
References|